Bimekizumab

Item number	Size	Delivery time	Price
TGM-T76798-1mg	1 mg	5 - 10 business days*	352.00€
TGM-T76798-5mg	5 mg	5 - 10 business days*	746.00€
TGM-T76798-10mg	10 mg	5 - 10 business days*	1,165.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody), a humanized monoclonal... more

Close menu

Product information "Bimekizumab"

Description: Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody), a humanized monoclonal antibody, selectively neutralizes IL-17A and IL-17F, which promote osteogenic differentiation in human periosteum-derived cells (hPDC), and consequently inhibits inflammation-driven osteogenic differentiation [1].

Supplier:	TargetMol
Supplier-Nr:	T76798

Properties

Application:	Targets interleukin 17A (IL17A, CTLA8)
Conjugate:	No

Database Information

CAS :	1418205-77-2\| Matching products
KEGG ID :	K05489 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Bimekizumab"

Write a review